Thus, BRCA1 expression is decreased or absent in a significant proportion of sporadic breast and ovarian cancer cases, in part because of hypermethylation of the BRCA1 promoter on CpG islands (Wilson et al, 1999; Rice et al, 2000). This evidence concerns the gene BRCA1 and ovarian cancer.